At Santen, we’re innovating therapies to improve the quality of life for patients worldwide. Our single focus in ophthalmology enables us to challenge unmet needs in the field-through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future. As a global company, Santen is often expanding to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution. Our clinical development network now spans three continents, with centers in EMEA (Europe, the Middle East and Africa), Japan, and the United States. Santen Global Santen United States SantenUSA.com/ Santen EMEA Japan
2
Total Investments
2
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Santen Ventures
Recent Investments (2)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Jul 2020 | |
| Series A | •••••• | Jul 2018 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.